Research ExplorerPublicationsNew Strategies for the Treatment of Atrial Fibrillation

New Strategies for the Treatment of Atrial Fibrillation

Standard

New Strategies for the Treatment of Atrial Fibrillation. / Jost, Norbert; Christ, Torsten; Magyar, János.

In: PHARMACEUTICALS-BASE, Vol. 14, No. 9, 926, 15.09.2021.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Jost, N, Christ, T & Magyar, J 2021, 'New Strategies for the Treatment of Atrial Fibrillation', PHARMACEUTICALS-BASE, vol. 14, no. 9, 926. https://doi.org/10.3390/ph14090926

APA

Jost, N., Christ, T., & Magyar, J. (2021). New Strategies for the Treatment of Atrial Fibrillation. PHARMACEUTICALS-BASE, 14(9), [926]. https://doi.org/10.3390/ph14090926

Vancouver

Jost N, Christ T, Magyar J. New Strategies for the Treatment of Atrial Fibrillation. PHARMACEUTICALS-BASE. 2021 Sep 15;14(9). 926. https://doi.org/10.3390/ph14090926

Bibtex

@article{c02187bdb28b4e18a41532d83c0f4e73,
title = "New Strategies for the Treatment of Atrial Fibrillation",
abstract = "Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the clinical practice. It significantly contributes to the morbidity and mortality of the elderly population. Over the past 25-30 years intense effort in basic research has advanced the understanding of the relationship between the pathophysiology of AF and atrial remodelling. Nowadays it is clear that the various forms of atrial remodelling (electrical, contractile and structural) play crucial role in initiating and maintaining the persistent and permanent types of AF. Unlike in ventricular fibrillation, in AF rapid ectopic firing originating from pulmonary veins and re-entry mechanism may induce and maintain (due to atrial remodelling) this complex cardiac arrhythmia. The present review presents and discusses in detail the latest knowledge on the role of remodelling in AF. Special attention is paid to novel concepts and pharmacological targets presumably relevant to the drug treatment of atrial fibrillation.",
author = "Norbert Jost and Torsten Christ and J{\'a}nos Magyar",
year = "2021",
month = sep,
day = "15",
doi = "10.3390/ph14090926",
language = "English",
volume = "14",
journal = "PHARMACEUTICALS-BASE",
issn = "1424-8247",
publisher = "Multidisciplinary Digital Publishing Institute",
number = "9",

}

RIS

TY - JOUR

T1 - New Strategies for the Treatment of Atrial Fibrillation

AU - Jost, Norbert

AU - Christ, Torsten

AU - Magyar, János

PY - 2021/9/15

Y1 - 2021/9/15

N2 - Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the clinical practice. It significantly contributes to the morbidity and mortality of the elderly population. Over the past 25-30 years intense effort in basic research has advanced the understanding of the relationship between the pathophysiology of AF and atrial remodelling. Nowadays it is clear that the various forms of atrial remodelling (electrical, contractile and structural) play crucial role in initiating and maintaining the persistent and permanent types of AF. Unlike in ventricular fibrillation, in AF rapid ectopic firing originating from pulmonary veins and re-entry mechanism may induce and maintain (due to atrial remodelling) this complex cardiac arrhythmia. The present review presents and discusses in detail the latest knowledge on the role of remodelling in AF. Special attention is paid to novel concepts and pharmacological targets presumably relevant to the drug treatment of atrial fibrillation.

AB - Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in the clinical practice. It significantly contributes to the morbidity and mortality of the elderly population. Over the past 25-30 years intense effort in basic research has advanced the understanding of the relationship between the pathophysiology of AF and atrial remodelling. Nowadays it is clear that the various forms of atrial remodelling (electrical, contractile and structural) play crucial role in initiating and maintaining the persistent and permanent types of AF. Unlike in ventricular fibrillation, in AF rapid ectopic firing originating from pulmonary veins and re-entry mechanism may induce and maintain (due to atrial remodelling) this complex cardiac arrhythmia. The present review presents and discusses in detail the latest knowledge on the role of remodelling in AF. Special attention is paid to novel concepts and pharmacological targets presumably relevant to the drug treatment of atrial fibrillation.

U2 - 10.3390/ph14090926

DO - 10.3390/ph14090926

M3 - SCORING: Review article

C2 - 34577626

VL - 14

JO - PHARMACEUTICALS-BASE

JF - PHARMACEUTICALS-BASE

SN - 1424-8247

IS - 9

M1 - 926

ER -